The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2015

Filed:

Jan. 11, 2010
Applicants:

Yu Hoshino, Irvine, CA (US);

Kenneth J. Shea, Irvine, CA (US);

Inventors:

Yu Hoshino, Irvine, CA (US);

Kenneth J. Shea, Irvine, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/42 (2006.01); C08F 2/10 (2006.01); C08F 2/44 (2006.01); A61K 9/51 (2006.01); B01D 15/38 (2006.01); B01J 20/26 (2006.01); B01J 20/28 (2006.01); B82Y 5/00 (2011.01); B82Y 30/00 (2011.01); C07K 1/22 (2006.01); G01N 33/543 (2006.01);
U.S. Cl.
CPC ...
A61K 47/32 (2013.01); A61K 9/5138 (2013.01); A61K 9/5192 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); B01D 15/3852 (2013.01); B01J 20/261 (2013.01); B01J 20/267 (2013.01); B01J 20/268 (2013.01); B01J 20/28007 (2013.01); B82Y 5/00 (2013.01); B82Y 30/00 (2013.01); C07K 1/22 (2013.01); C08F 2/10 (2013.01); C08F 2/44 (2013.01); G01N 33/5432 (2013.01); G01N 33/54346 (2013.01); G01N 2600/00 (2013.01);
Abstract

The present invention relates to imprinted polymer nanoparticles. In particular, the present invention provides imprinted polymer nanoparticles polymerized in the presence of a target molecule (e.g., peptide), wherein the imprinted polymer nanoparticles comprise vinyl, acryl, and/or methacryl monomers, wherein the monomers have affinity for the target molecule. The present invention also relates to methods of using imprinted polymer nanoparticles in biomacromolecular purification methods (e.g., to purify monoclonal antibodies or hormones), in toxin elimination methods (e.g., hemoperfusion), in diagnostics, in research, as well as in therapeutic methods (e.g., therapeutic methods where antisera or monoclonal antibodies are normally employed).


Find Patent Forward Citations

Loading…